Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $103.3 million.

  • Anaptysbio's Cash from Investing Activities rose 7618.9% to $103.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.1 million, marking a year-over-year decrease of 2807.12%. This contributed to the annual value of $95.4 million for FY2024, which is 3409.65% down from last year.
  • As of Q3 2025, Anaptysbio's Cash from Investing Activities stood at $103.3 million, which was up 7618.9% from $36.4 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Cash from Investing Activities registered a high of $103.3 million during Q3 2025, and its lowest value of -$312.9 million during Q1 2022.
  • Over the past 5 years, Anaptysbio's median Cash from Investing Activities value was $21.5 million (recorded in 2022), while the average stood at $2.0 million.
  • As far as peak fluctuations go, Anaptysbio's Cash from Investing Activities plummeted by 195364.09% in 2021, and later skyrocketed by 159070.43% in 2025.
  • Anaptysbio's Cash from Investing Activities (Quarter) stood at -$66.7 million in 2021, then soared by 132.23% to $21.5 million in 2022, then surged by 128.77% to $49.2 million in 2023, then crashed by 159.77% to -$29.4 million in 2024, then soared by 451.35% to $103.3 million in 2025.
  • Its last three reported values are $103.3 million in Q3 2025, $36.4 million for Q2 2025, and $14.8 million during Q1 2025.